Roche
This article was originally published in The Tan Sheet
Executive Summary
Announces "substantial" reduction in prices for vitamin B[1] and B[6] in response to "softening market prices" on July 12. Roche said its pricing decision is "feasible" due to "significant technological improvements and streamlining of the production processes for the two vitamins" and to a consolidation of production sites for B[1]